No photo of Andrew Gillman

Andrew Gillman

Dr

20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

A Multicentre, Double-Blind, Randomized, Placebo Controlled, Parallel group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (DESTINATION)

Gillman, A. & Hazard, A.

2/12/19 → 1/05/22

Project: Research

A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (NAVIGATOR).

Gillman, A. & Hazard, A.

2/12/19 → 31/12/20

Project: Research

Research Output

Coexisting atopic conditions influence the likelihood of allergic bronchopulmonary aspergillosis in asthma

Tay, T. R., Bosco, J., Gillman, A., Aumann, H., Stirling, R., O'Hehir, R. & Hew, M., Jul 2016, In : Annals of Allergy, Asthma and Immunology. 117, 1, p. 29-32 5 p.

Research output: Contribution to journal › Article › Research › peer-review

6 Citations (Scopus)

Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry

Gibson, P. G., Reddel, H. K., McDonald, V. M., Marks, G. B., Jenkins, C., Gillman, A., Upham, J., Sutherland, M., Rimmer, J., Thien, F., Katsoulotos, G. P., Cook, M., Yang, I., Katelaris, C. H., Bowler, S., Langton, D., Robinson, P., Wright, C., Yozghatlian, V., Burgess, S. & 11 others, Sivakumaran, P., Jaffe, A., Bowden, J., Wark, P. A. B., Yan, K. Y., Kritikos, V., Peters, M., Hew, M., Aminazad, A., Fonseka, M. M. & Guo, M., 1 Sep 2016, In : Internal Medicine Journal. 46, 9, p. 1054-1062 9 p.

Research output: Contribution to journal › Article › Research › peer-review

34 Citations (Scopus)

Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria

Hew, M., Gillman, A., Sutherland, M., Wark, P., Bowden, J., Guo, M., Reddel, H. K., Jenkins, C., Marks, G. B., Thien, F., Rimmer, J., Katsoulotos, G. P., Cook, M., Yang, I., Katelaris, C. H., Bowler, S., Langton, D., Wright, C., Fonseka, M. M., Yozghatlian, V. & 13 others, Burgess, S., Sivakumaran, P., Yan, K. Y., Kritikos, V., Peters, M., Baraket, M., Aminazad, A., Robinson, P., Jaffe, A., Powell, H., Upham, J. W., McDonald, V. M. & Gibson, P. G., 1 Nov 2016, In : Clinical & Experimental Allergy. 46, 11, p. 1407-1415 9 p.

Research output: Contribution to journal › Article › Research › peer-review

19 Citations (Scopus)

Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis

Voskamp, A. L., Gillman, A., Symons, K., Sandrini Lopes de Souza, A., Rolland, J. M., O'Hehir, R. E. & Douglass, J. A., 2015, In : Journal of Allergy and Clinical Immunology: In Practice. 3, 2, p. 192 - 199 8 p.

Research output: Contribution to journal › Article › Research › peer-review

65 Citations (Scopus)

Comparison of supine-only and REM only obstructive sleep apnoea

Gillman, A., Ho, S., Roebuck, T., Van Braak, E. & Naughton, M. T., 2012, In : Sleep Medicine. 13, 7, p. 875 - 878 4 p.

Research output: Contribution to journal › Article › Research › peer-review

13 Citations (Scopus)